Pharm
Quetiapine
search
Quetiapine
, Seroquel
See Also
Quetiapine Overdose
Antipsychotic Medication
Psychosis
Class
Atypical Antipsychotic
(Second
Gene
ration
Antipsychotic
)
Neuroleptic
Dibenzothiazepine
Antipsychotic
Mechanism
Stronger
Antagonist
at
Serotonin
5HT2 receptors than
Dopamine
D2 receptors
Potent alpha-1
Adrenergic Receptor
Antagonist
(risk of
Hypotension
)
Weak
Antagonist
at
Dopamine
(D2),
Histamine
muscarinic (M1) and
Serotonin
(5HT-1A) with risk of sedation
Indications
Schizophrenia
Psychosis in Dementia
Bipolar Disorder
Mania
Major Depression
(adjunct)
Autism
(not FDA approved)
Insomnia
(not FDA approved)
Obsessive Compulsive Disorder
(not FDA approved)
Generalized Anxiety Disorder
(not FDA approved)
Precautions
Use lower doses and slower titration in the elderly and liver dysfunction
Start at 25 mg/day and increase by no more than 25 to 50 mg/day
Restart dose titration if Quetiapine was stopped for more than 7 days
Low risk of
Tardive Dyskinesia
and
Extrapyramidal Side Effect
s
Dosing
Schizophrenia
Adults (or Children age 13 to 17 years) Regular Immediate Release Oral Tablets
Initial: 25 mg orally twice daily
Increase in 25-50 mg/day increments divided 2-3 times daily
Example of a more rapid titration
Day 1: Take 25 mg orally twice daily
Day 2: Take 50 mg orally twice daily
Day 3: Take 100 mg orally twice daily
Day 4: Take 150 mg orally twice daily
Day 5: Take 200 mg orally twice daily
Target: 300-400 mg/day orally divided twice to three times daily
Maximum dose: 800 mg/day
Adults (or Children age 13 to 17 years) Sustained Release Tablets (Seroquel XR)
Avoid taking Sustained Release Tablets with food
May start at up to 300 mg orally each evening at bedtime
May increase up to 300 mg/day
Example of dose titration
Dose 1: Take 50 mg orally at bedtime
Dose 2: Take 100 mg orally at bedtime
Dose 3: Take 200 mg orally at bedtime
Dose 4: Take 300 mg orally at bedtime
Dose 5: Take 400 mg orally at bedtime
Target 400 to 800 mg/day
Maximum 800 mg/day
Dosing
Acute Bipolar
Mania
or Mixed Disorder
Adults Regular (or Children age 13 to 17 years) Immediate Release Oral Tablets
Day 1: Start 50 mg orally twice daily
Day 2: Take 100 mg orally twice daily
Day 3: Take 150 mg orally twice daily
Day 4: Take 200 mg orally twice daily
Day 5: Take 300 mg orally twice daily
Day 6: Take 400 mg orally twice daily
Target: 400 to 600 mg/day (up to 800 mg/day in adults)
Maximum: 600 mg/day (up to 800 mg/day in adults)
Adults (or Children age 13 to 17 years) Extended Release Oral Tablets (Seroquel XR)
Avoid taking Sustained Release Tablets with food
May consider rapid start higher dosing in adults (or use titrating dose below)
Day 1: 300 mg orally at bedtime
Day 2: 600 mg orally daily bedtime
Titrate to dose in children age 13 to 17 years
Day 1: Start 50 mg orally at bedtime
Day 2: Take 100 mg orally at bedtime
Day 3: Take 200 mg orally at bedtime
Day 4: Take 300 mg orally at bedtime
Day 5: Take 400 mg orally at bedtime
Target: 400 to 600 mg orally daily each evening (up to 800 mg/day in adults)
Maximum: 600 mg/day (up to 800 mg/day in adults)
Dosing
Bipolar Depression
or
Major Depression
Adults Extended Release Oral Tablets (Seroquel XR)
Titrate rapidly as below in
Bipolar Depression
(more gradually in
Major Depression
)
Day 1: Start 50 mg orally at bedtime
Day 2: Take 100 mg orally at bedtime
Day 3: Take 200 mg orally at bedtime
Day 4: Take 300 mg orally at bedtime
Continue 300 mg orally daily at bedtime
Maximum: 30 mg/day
Dosing
Miscellaneous
Adults with Refractory
Insomnia
(not FDA approved)
Start 50 mg orally at bedtime
Titrate as needed to effect
Maximum: 400 mg
Elderly Regular Oral Tablets
Initial dose: 12.5 mg orally at bedtime
Titrate dose every few days (caution due to sedation)
Pharmacokinetics
Quetiapine Regular Tablets
Use lower doses and slower titration in the elderly and liver dysfunction
Lipophilic
Large volume of distribution (10 L/kg +/-4 L/kg)
Plasma
Protein
binding: 83%
Not dialyzable
Half-Life
: 6 hours
Peak Levels: 2-3 hours
Metabolism: CYP 3A4
Adverse Effects
Gene
ral
Sedation
Headache
Orthostatic Hypotension
Cataract
formation
Dry Mouth
(although
Anticholinergic
effects are minimal with Quetiapine)
Weight gain
Hyperglycemia
and increased risk of
Diabetes Mellitus
Neuroleptic Malignant Syndrome
QTc Prolongation
Adverse Effects
Overdose
See
Quetiapine Overdose
Somnolence
Tachycardia
Hypotension
Drug Interactions
Metabolized by
CYP3A4
Decrease dose to one-sixth of typical dose when on strong
CYP3A4
inhibitors
Increase dose (as much as 5 fold) when on stong
CYP3A4
inducers
Increase
Antipsychotic
levels (toxicity risk): Monitor for toxicity
Clarithromycin
Erythromycin
Grapefruit
juice
Fluconazole
Itraconazole
Ketoconazole
Quinidine
Decrease
Antipsychotic
levels (lower efficacy)
Barbiturate
s
Carbamazepine
Phenytoin
Rifampin
Theophylline
Other effects
Avoid concurrent use of other medications prolonging
QT Interval
See
Prolonged QT Interval due to Medication
Safety
Pregnancy Category C
Avoid in
Lactation
Monitoring
See
Quetiapine Overdose
See
Antipsychotic
Screen for
Cataract
formation every 6 months
Consider EKG,
Electrolyte
and
Magnesium
monitoring due to
QT Interval
prolongation risk
Monitor weight,
Fastin
g
Glucose
and
Serum Triglyceride
s (at baseline and periodically)
Resources
Quetiapine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b7d7d2f-a50b-8e21-2de4-ccc102016384
References
(2016) Med Lett Drugs Ther 58(1510): 160-5
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 42-3
Otter and Tomaszewski (2018) Crit Dec Emerg Med 32(8): 32
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here